Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF Efficacy in Chemotherapy-Induced Neutropenia
NCT03498248Unknown
- Start
- Feb 2018
- Primary completion
- Aug 2018
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Open-label, single-arm trial of lenograstim in neutropenia. Primary endpoint: duration of severe neutropenia. Status: unknown.
02
Drugs
lenograstim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT03498248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03498248.